ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

DSP Healthcare Fund

DSP DSP Mutual Fund Jan 2022 — Sep 2026 56 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹3,148 CrAt NSE closes, Sep 2026
Companies held2727 with an NSE price
Top 10 holdings68.3%Of the equity shown here
Largest holding9.7%IPCA Laboratories Limited
12-month turnover25.0%Estimated from 11 monthly disclosures · compare

Days to sell half: 11.7 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

56 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

68.3% now, 75.0% in Sep 2025 · highest 82.4%, lowest 67.9%

Companies held

27 now, 24 in Sep 2025 · largest single holding 9.7% of equity

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. NIPPON INDIA PHARMA FUNDNippon India · 15 shared45.2%
  2. ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 16 shared44.2%
  3. ICICI Prudential Healthcare FundICICI Prudential · 16 shared42.5%
  4. UTI - Healthcare FundUTI · 18 shared42.3%
  5. ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Prudential · 14 shared40.8%
  6. HDFC Pharma and Healthcare FundHDFC · 14 shared37.9%
  7. Bandhan Healthcare FundBandhan · 11 shared37.8%
  8. WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 15 shared36.9%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 1 Companies added
Complete exits 0 Companies sold out
Increases 2 More shares than last month
Reductions 3 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
IPCA Laboratories Limited Healthcare Mid Cap 9.69% 305 Cr 0.16 Cr by Jan 2022 (56 mo+)
Sun Pharmaceutical Industries Limited Healthcare Large Cap 8.86% 279 Cr 0.15 Cr by Jan 2022 (56 mo+)
Cipla Limited Healthcare Large Cap 8.56% 269 Cr 0.20 Cr by Jan 2022 (56 mo+)
Sai Life Sciences Limited Healthcare Small Cap 7.76% 244 Cr 0.16 Cr Dec 2024 (22 mo)
Gland Pharma Limited Healthcare Small Cap 7.32% 231 Cr 0.08 Cr Jun 2024 (28 mo)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 7.23% 228 Cr 0.03 Cr by Jan 2022 (56 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 5.65% 178 Cr 0.03 Cr by Jan 2022 (56 mo+)
Divi's Laboratories Limited Healthcare Large Cap 4.96% 156 Cr 0.02 Cr Jul 2026 (3 mo)
Cohance Lifesciences Limited Healthcare Small Cap 4.52% 142 Cr 0.32 Cr Oct 2022 (47 mo)
Alembic Pharmaceuticals Limited Not classified Small Cap 3.78% 119 Cr 0.14 Cr by Jan 2022 (56 mo+)
Kovai Medical Center & Hospital Limited Not classified Small Cap 3.37% 106 Cr 0.02 Cr by Jan 2022 (56 mo+)
Pfizer Limited Healthcare Small Cap 3.24% 102 Cr 0.03 Cr Oct 2022 (47 mo)
Concord Biotech Limited Healthcare Small Cap 3.21% 101 Cr 0.07 Cr Aug 2023 (37 mo)
Procter & Gamble Health Limited Healthcare Small Cap 2.81% 88.61 Cr 0.02 Cr by Jan 2022 (56 mo+)
Vijaya Diagnostic Centre Limited Healthcare Small Cap 2.81% 88.52 Cr 0.06 Cr by Jan 2022 (56 mo+)
Indoco Remedies Limited Not classified Small Cap 2.70% 84.93 Cr 0.32 Cr by Jan 2022 (56 mo+)
Thyrocare Technologies Limited Healthcare Small Cap 2.28% 71.64 Cr 0.13 Cr Aug 2026 (2 mo)
Manipal Health Enterprises Limited Not classified — 2.20% 69.42 Cr 0.10 Cr Jul 2026 (3 mo)
Unichem Laboratories Limited Not classified Small Cap 1.96% 61.57 Cr 0.11 Cr Jun 2023 (39 mo)
Syngene International Limited Healthcare Small Cap 1.61% 50.60 Cr 0.14 Cr Jun 2026 (4 mo)
Nephrocare Health Services Limited Healthcare Small Cap 1.33% 41.89 Cr 0.06 Cr Dec 2025 (10 mo)
ICICI Lombard General Insurance Company Limited Financial Services Mid Cap 1.22% 38.38 Cr 0.02 Cr by Jan 2022 (56 mo+)
Aarti Drugs Limited Not classified Small Cap 1.17% 36.72 Cr 0.09 Cr by Jan 2022 (56 mo+)
Eris Lifesciences Limited Healthcare Small Cap 0.86% 26.92 Cr 0.02 Cr Jul 2026 (3 mo)
Jupiter Life Line Hospitals Limited Not classified Small Cap 0.42% 13.10 Cr 0.05 Cr Sep 2023 (36 mo)
Abbott India Limited Healthcare Mid Cap 0.32% 9.92 Cr 3,658 Sep 2026 (1 mo)
Laxmi Dental Limited Not classified Small Cap 0.17% 5.37 Cr 0.03 Cr Jan 2025 (21 mo)

Half of its current holdings have been held for 47 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Manipal Health Enterprises Limited Sep 2026 ▼ Reducing -0.09 Cr
Sai Life Sciences Limited Sep 2026 ▼ Reducing -0.04 Cr
Syngene International Limited Sep 2026 ▲ Increasing +0.01 Cr
IPCA Laboratories Limited Sep 2026 ▼ Reducing -0.01 Cr
Alkem Laboratories Limited Sep 2026 ▲ Increasing +50,793
Abbott India Limited Sep 2026 ▲ New position +3,658
Thyrocare Technologies Limited Aug 2026 ▲ New position +0.13 Cr
Vijaya Diagnostic Centre Limited Aug 2026 ▼ Reducing -0.03 Cr
Concord Biotech Limited Aug 2026 ▲ Increasing +0.02 Cr
Gland Pharma Limited Aug 2026 ▼ Reducing -0.01 Cr
Divi's Laboratories Limited Aug 2026 ▲ Increasing +62,975
Pfizer Limited Aug 2026 ▲ Increasing +57,949
Apollo Hospitals Enterprise Limited Aug 2026 ▲ Increasing +43,297
Kovai Medical Center & Hospital Limited Aug 2026 ▲ Increasing +8,810
Unichem Laboratories Limited Aug 2026 ▲ Increasing +4,171
Manipal Health Enterprises Limited Jul 2026 ▲ New position +0.19 Cr
Eris Lifesciences Limited Jul 2026 ▲ New position +0.02 Cr
Syngene International Limited Jul 2026 ▲ Increasing +0.01 Cr
Alkem Laboratories Limited Jul 2026 ▲ Increasing +0.01 Cr
Divi's Laboratories Limited Jul 2026 ▲ New position +0.01 Cr
Emcure Pharmaceuticals Limited Jul 2026 ▼ Complete exit -69,966
Jupiter Life Line Hospitals Limited Jul 2026 ▲ Increasing +45,950
Apollo Hospitals Enterprise Limited Jul 2026 ▲ Increasing +40,665
Cohance Lifesciences Limited Jul 2026 ▲ Increasing +23,118
Unichem Laboratories Limited Jul 2026 ▲ Increasing +13,881
Pfizer Limited Jul 2026 ▲ Increasing +5,034
Syngene International Limited Jun 2026 ▲ New position +0.11 Cr
Laurus Labs Limited Jun 2026 ▼ Complete exit -0.09 Cr
Unichem Laboratories Limited Jun 2026 ▲ Increasing +0.03 Cr
Emcure Pharmaceuticals Limited Jun 2026 ▼ Reducing -0.02 Cr
Cipla Limited Jun 2026 ▲ Increasing +0.02 Cr
Alkem Laboratories Limited Jun 2026 ▲ Increasing +0.01 Cr
Kovai Medical Center & Hospital Limited Jun 2026 ▲ Increasing +2,849
Laurus Labs Limited May 2026 ▼ Reducing -0.09 Cr
Medplus Health Services Limited May 2026 ▼ Complete exit -0.02 Cr
Sai Life Sciences Limited May 2026 ▲ Increasing +0.02 Cr
Emcure Pharmaceuticals Limited May 2026 ▼ Reducing -82,806
Cohance Lifesciences Limited May 2026 ▲ Increasing +39,251
CORONA Remedies Limited May 2026 ▼ Complete exit -27,314
Alembic Pharmaceuticals Limited May 2026 ▲ Increasing +14,336
Indoco Remedies Limited May 2026 ▲ Increasing +12,208
Unichem Laboratories Limited May 2026 ▲ Increasing +3,048
Cohance Lifesciences Limited Apr 2026 ▲ Increasing +0.02 Cr
CORONA Remedies Limited Apr 2026 ▼ Reducing -89,656
Emcure Pharmaceuticals Limited Apr 2026 ▼ Reducing -11,389
Concord Biotech Limited Feb 2026 ▲ Increasing +6,914
Thyrocare Technologies Limited Jan 2026 ▼ Complete exit -42,573
Cipla Limited Jan 2026 ▲ Increasing +22,981
Cohance Lifesciences Limited Jan 2026 ▲ Increasing +4,613
Nephrocare Health Services Limited Dec 2025 ▲ New position +0.06 Cr
CORONA Remedies Limited Dec 2025 ▲ New position +0.01 Cr
Laurus Labs Limited Dec 2025 ▼ Reducing -81,858
Thyrocare Technologies Limited Dec 2025 ▼ Reducing -36,155
Thyrocare Technologies Limited Nov 2025 ▼ Reducing -0.05 Cr
Laurus Labs Limited Nov 2025 ▼ Reducing -0.03 Cr
Emcure Pharmaceuticals Limited Nov 2025 ▼ Reducing -5,202
Cohance Lifesciences Limited Oct 2025 ▲ Increasing +0.02 Cr
Sai Life Sciences Limited Oct 2025 ▲ Increasing +89,231
Cohance Lifesciences Limited Sep 2025 ▲ Increasing +0.02 Cr
Cohance Lifesciences Limited Aug 2025 ▲ Increasing +0.01 Cr
Thyrocare Technologies Limited Aug 2025 ▼ Reducing -45,395
Emcure Pharmaceuticals Limited Jul 2025 ▲ Increasing +50,513
Narayana Hrudayalaya Ltd. Jun 2025 ▼ Complete exit -0.01 Cr
Sai Life Sciences Limited Jun 2025 ▲ Increasing +0.01 Cr
Procter & Gamble Health Limited Jun 2025 ▲ Increasing +584
Narayana Hrudayalaya Ltd. May 2025 ▼ Reducing -0.01 Cr
Sun Pharmaceutical Industries Limited Apr 2025 ▼ Reducing -0.03 Cr
IPCA Laboratories Limited Apr 2025 ▲ Increasing +92,396
Vijaya Diagnostic Centre Limited Apr 2025 ▼ Reducing -83,542
Narayana Hrudayalaya Ltd. Apr 2025 ▼ Reducing -72,739
Unichem Laboratories Limited Apr 2025 ▲ Increasing +8,205
Alembic Pharmaceuticals Limited Apr 2025 ▲ Increasing +4,617
Jupiter Life Line Hospitals Limited Apr 2025 ▼ Reducing -2,361
Lupin Limited Mar 2025 ▼ Complete exit -80,146
Unichem Laboratories Limited Feb 2025 ▲ Increasing +0.01 Cr
Concord Biotech Limited Feb 2025 ▼ Reducing -94,192
Laurus Labs Limited Feb 2025 ▼ Reducing -37,473
Aarti Drugs Limited Feb 2025 ▲ Increasing +13,347
Pfizer Limited Feb 2025 ▲ Increasing +1,802
Laurus Labs Limited Jan 2025 ▲ Increasing +0.03 Cr
Laxmi Dental Limited Jan 2025 ▲ New position +0.03 Cr
Thyrocare Technologies Limited Jan 2025 ▲ Increasing +0.02 Cr
Gland Pharma Limited Jan 2025 ▲ Increasing +98,132
Indoco Remedies Limited Jan 2025 ▲ Increasing +47,343
Aarti Drugs Limited Jan 2025 ▲ Increasing +30,541
Pfizer Limited Jan 2025 ▲ Increasing +21,002
Sai Life Sciences Limited Jan 2025 ▲ Increasing +18,186
Apollo Hospitals Enterprise Limited Jan 2025 ▲ Increasing +8,561
Sai Life Sciences Limited Dec 2024 ▲ New position +0.16 Cr
Cipla Limited Dec 2024 ▲ Increasing +0.01 Cr
Aarti Drugs Limited Dec 2024 ▲ Increasing +75,574
Pfizer Limited Dec 2024 ▲ Increasing +33,703
Indoco Remedies Limited Nov 2024 ▲ Increasing +0.07 Cr
Laurus Labs Limited Nov 2024 ▲ Increasing +0.05 Cr
Lupin Limited Nov 2024 ▼ Reducing -0.05 Cr
Cipla Limited Nov 2024 ▲ Increasing +0.03 Cr
Cohance Lifesciences Limited Nov 2024 ▼ Reducing -96,395
Narayana Hrudayalaya Ltd. Nov 2024 ▲ Increasing +23,366
Laurus Labs Limited Oct 2024 ▲ New position +0.14 Cr
Lupin Limited Oct 2024 ▼ Reducing -0.05 Cr

Changes compare consecutive month-end disclosures for this portfolio only.